Alpha 2.0
Login Register
» Authors » Dhruba J Bharali

Dhruba J Bharali

Explore the profile of Dhruba J Bharali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 1230
Followers 0
Related Specialties
Biotechnology
Oncology
Biomedical Engineering
Top 10 Co-Authors
Shaker A Mousa
Thangirala Sudha
Paul J Davis
Murat Yalcin
Kavitha Godugu
Huadong Cui
Imtiaz A Siddiqui
Hung-Yun Lin
Hasan Mukhtar
Vaqar M Adhami
Published In
Nanomedicine
Int J Nanomedicine
Pharm Res
Bioconjug Chem
Nanomedicine (Lond)
Affiliations
Soon will be listed here.
Recent Articles
1.
Editorial Expression of Concern: Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer
Hariri W, Sudha T, Bharali D, Cui H, Mousa S
Pharm Res . 2025 Mar; PMID: 40087236
No abstract available.
2.
Retraction Note: Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle
Li W, Yalcin M, Bharali D, Lin Q, Godugu K, Fujioka K, et al.
Sci Rep . 2023 Oct; 13(1):16594. PMID: 37789122
No abstract available.
3.
Editorial Expression of Concern: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles
Yalcin M, Lin H, Sudha T, Bharali D, Meng R, Tang H, et al.
Discov Oncol . 2023 May; 14(1):75. PMID: 37213035
No abstract available.
4.
Correction to "Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin αβ Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme"
Rajabi M, Godugu K, Sudha T, Bharali D, Mousa S
Bioconjug Chem . 2023 Jan; 34(2):453. PMID: 36709499
No abstract available.
5.
Corrigendum to "Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia" [Nanomedicine 40 (2022 Feb); 102480. doi: 10.1016/j.nano.2021.102480]
Salaheldin T, Godugu K, Bharali D, Fujioka K, Elshourbagy N, Mousa S
Nanomedicine . 2022 Sep; 46:102602. PMID: 36152475
No abstract available.
6.
Novel Pomegranate-Nanoparticles Ameliorate Cisplatin-Induced Nephrotoxicity and Improves Cisplatin Anti-Cancer Efficacy in Ehrlich Carcinoma Mice Model
Harakeh S, Almuhayawi M, Akefe I, Saber S, Al Jaouni S, Alzughaibi T, et al.
Molecules . 2022 Mar; 27(5). PMID: 35268707
Cisplatin (CISP) is one of the most widely used anti-cancer chemotherapeutic agents with remarkable efficacy against various types of cancers. However, it has been associated with nephrotoxicity amongst other undesirable...
7.
Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia
Salaheldin T, Godugu K, Bharali D, Fujioka K, Elshourbagy N, Mousa S
Nanomedicine . 2021 Nov; 40:102480. PMID: 34748962
Proprotein convertase subtilisin/kexin type 9 is a protease enzyme secreted by liver that downregulates hepatic low-density lipoprotein receptor (LDLR) by binding and chaperoning LDLR to lysosomes for degradation, causing hypercholesteremia....
8.
Correction to "Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin αβ Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme"
Rajabi M, Godugu K, Sudha T, Bharali D, Mousa S
Bioconjug Chem . 2021 Mar; 32(4):859. PMID: 33689298
No abstract available.
9.
A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer's Disease
Harakeh S, Qari M, Ramadan W, Al Jaouni S, Almuhayawi M, Al Amri T, et al.
Curr Drug Metab . 2020 Dec; 22(4):299-307. PMID: 33327909
Background: Aluminum toxicity induces neurodegenerative changes in the brain and results in Alzheimer's disease (AD). Objective: Here, the aim was to evaluate the antioxidant therapeutic effects of ellagic acid (EA)...
10.
The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model
Almuhayawi M, Ramadan W, Harakeh S, Al Jaouni S, Bharali D, Mousa S, et al.
Saudi J Biol Sci . 2020 Jun; 27(7):1710-1716. PMID: 32565686
The oxidative stress leading to degenerative changes in the brain of Alzheimer's disease (AD) is evident. Our aim was to evaluate the therapeutic and protective effects of pomegranate extract (PE)...